This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Study of Cingal for the Relief of Knee Osteoarthri...
Clinical trial

Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide

Read time: 2 mins
Last updated:25th May 2017
Identifier: NCT03191903

This is a multi-center, randomized, double-blind, parallel group, active comparator controlled trial to evaluate the efficacy and safety of a single injection of Cingal for the relief of joint pain in subjects with OA of the knee.


Study Type: Interventional  (Clinical Trial)
Actual Enrollment: 576 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Randomized, Double-Blind, Active Comparator Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal™) to Provide Symptomatic Relief of Osteoarthritis of the Knee
Actual Study Start Date: May 25, 2017
Actual Primary Completion Date: April 23, 2018
Actual Study Completion Date: April 23, 2018

Arm:
- Experimental:
Cingal
- Active Comparator: Monovisc
- Active Comparator: Triamcinolone Hexacetonide (TH)

Category Value
Date last updated at source 2018-05-23
Study type(s) Interventional
Expected enrolment 576
Study start date 2017-05-25
Estimated primary completion date 2018-04-23

View full details